Medpace Holdings Inc

MEDP: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
V>>LOCK|q??&NLOCK|#Xw@fr&

Medpace Earnings: Elevated Cancellations and Weak Gross Bookings Raise Concerns; Shares Tank 23%

Medpace reported 26% year-over-year revenue growth to $706 million in the first quarter, but its backlog declined $98 million sequentially to $2.93 billion amid elevated cancellations and weak bookings, driving a net book/bill ratio of only 0.88 versus 1.04 in the fourth quarter.

Sponsor Center